Last reviewed · How we verify
2%lidocaine with 1:80.000 epinphrine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
2%lidocaine with 1:80.000 epinphrine (2%lidocaine with 1:80.000 epinphrine) — University of Baghdad.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 2%lidocaine with 1:80.000 epinphrine TARGET | 2%lidocaine with 1:80.000 epinphrine | University of Baghdad | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 2%lidocaine with 1:80.000 epinphrine CI watch — RSS
- 2%lidocaine with 1:80.000 epinphrine CI watch — Atom
- 2%lidocaine with 1:80.000 epinphrine CI watch — JSON
- 2%lidocaine with 1:80.000 epinphrine alone — RSS
Cite this brief
Drug Landscape (2026). 2%lidocaine with 1:80.000 epinphrine — Competitive Intelligence Brief. https://druglandscape.com/ci/2-lidocaine-with-1-80-000-epinphrine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab